S&P 500   3,312.09 (-0.40%)
DOW   29,103.24 (-0.19%)
QQQ   224.32 (-0.12%)
AAPL   322.16 (+0.92%)
FB   219.92 (+0.07%)
MSFT   166.89 (+0.10%)
GOOGL   1,483.44 (-0.08%)
AMZN   1,878.40 (-0.33%)
CGC   24.08 (-1.95%)
NVDA   254.83 (+0.78%)
MU   58.79 (-0.69%)
GE   11.72 (-0.42%)
TSLA   564.85 (-1.28%)
AMD   51.27 (-0.85%)
T   38.69 (+0.13%)
ACB   2.02 (-2.42%)
F   9.02 (-1.31%)
NFLX   351.97 (+0.68%)
PRI   124.84 (-0.57%)
BAC   33.62 (-1.47%)
DIS   140.82 (-0.97%)
GILD   63.42 (-0.81%)
S&P 500   3,312.09 (-0.40%)
DOW   29,103.24 (-0.19%)
QQQ   224.32 (-0.12%)
AAPL   322.16 (+0.92%)
FB   219.92 (+0.07%)
MSFT   166.89 (+0.10%)
GOOGL   1,483.44 (-0.08%)
AMZN   1,878.40 (-0.33%)
CGC   24.08 (-1.95%)
NVDA   254.83 (+0.78%)
MU   58.79 (-0.69%)
GE   11.72 (-0.42%)
TSLA   564.85 (-1.28%)
AMD   51.27 (-0.85%)
T   38.69 (+0.13%)
ACB   2.02 (-2.42%)
F   9.02 (-1.31%)
NFLX   351.97 (+0.68%)
PRI   124.84 (-0.57%)
BAC   33.62 (-1.47%)
DIS   140.82 (-0.97%)
GILD   63.42 (-0.81%)
S&P 500   3,312.09 (-0.40%)
DOW   29,103.24 (-0.19%)
QQQ   224.32 (-0.12%)
AAPL   322.16 (+0.92%)
FB   219.92 (+0.07%)
MSFT   166.89 (+0.10%)
GOOGL   1,483.44 (-0.08%)
AMZN   1,878.40 (-0.33%)
CGC   24.08 (-1.95%)
NVDA   254.83 (+0.78%)
MU   58.79 (-0.69%)
GE   11.72 (-0.42%)
TSLA   564.85 (-1.28%)
AMD   51.27 (-0.85%)
T   38.69 (+0.13%)
ACB   2.02 (-2.42%)
F   9.02 (-1.31%)
NFLX   351.97 (+0.68%)
PRI   124.84 (-0.57%)
BAC   33.62 (-1.47%)
DIS   140.82 (-0.97%)
GILD   63.42 (-0.81%)
S&P 500   3,312.09 (-0.40%)
DOW   29,103.24 (-0.19%)
QQQ   224.32 (-0.12%)
AAPL   322.16 (+0.92%)
FB   219.92 (+0.07%)
MSFT   166.89 (+0.10%)
GOOGL   1,483.44 (-0.08%)
AMZN   1,878.40 (-0.33%)
CGC   24.08 (-1.95%)
NVDA   254.83 (+0.78%)
MU   58.79 (-0.69%)
GE   11.72 (-0.42%)
TSLA   564.85 (-1.28%)
AMD   51.27 (-0.85%)
T   38.69 (+0.13%)
ACB   2.02 (-2.42%)
F   9.02 (-1.31%)
NFLX   351.97 (+0.68%)
PRI   124.84 (-0.57%)
BAC   33.62 (-1.47%)
DIS   140.82 (-0.97%)
GILD   63.42 (-0.81%)
Log in

FRA:BAYN - Bayer Stock Price, Forecast & News

€75.41
+1.31 (+1.77 %)
(As of 01/24/2020 11:30 AM ET)
Today's Range
€75.04
Now: €75.41
€76.99
50-Day Range
€68.77
MA: €72.63
€75.75
52-Week Range
€91.58
Now: €75.41
€123.82
Volume3.15 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-214-301

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees111,015
Next Earnings DateN/A
OptionableNot Optionable

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.


Bayer (FRA:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

What price target have analysts set for BAYN?

19 equities research analysts have issued twelve-month price objectives for Bayer's shares. Their forecasts range from €61.00 to €123.00. On average, they expect Bayer's share price to reach €81.61 in the next twelve months. This suggests a possible upside of 8.2% from the stock's current price. View Analyst Price Targets for Bayer.

What is the consensus analysts' recommendation for Bayer?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 8 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bayer.

Has Bayer been receiving favorable news coverage?

Media stories about BAYN stock have been trending negative on Friday, according to InfoTrie. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bayer earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave media coverage about the healthcare company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Bayer.

Who are some of Bayer's key competitors?

What other stocks do shareholders of Bayer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include Hawkins (HWKN), CA (CA), Bayer (BAYRY), BlackRock (BLK), The Coca-Cola (KO), Endologix (ELGX), Basf (BAS), Alibaba Group (BABA), General Electric (GE) and ESSILOR INTL S/S (ESLOY).

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €75.41.

What is Bayer's official website?

The official website for Bayer is http://www.bayer.de/.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


MarketBeat Community Rating for Bayer (FRA BAYN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  1,482 (Vote Outperform)
Underperform Votes:  982 (Vote Underperform)
Total Votes:  2,464
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: Percentage Decliners

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel